Cirrhosis represents the end stage of chronic liver disease and its transition from a compensated to a decompensated status is mainly driven by portal hypertension and systemic inflammation. Although relevant modifications in the evaluation of the coagulative balance in cirrhosis across its natural history have occurred and alterations in routine indices of hemostasis have lost their role as indicators of the hemorrhagic risk of patients with liver cirrhosis, these are still perceived as prone to bleed when admitted to invasive procedures. This view, which is still present in guidelines addressing the management of bleeding risk, makes preprocedural transfusion of plasma and platelets still an ongoing clinical practice. In this review, we describe the limitations of both bleeding risk assessment in cirrhotic patients admitted to radiologic and endoscopic invasive procedures and evaluate whether preventive strategies indicated by current guidelines can affect the procedure-related hemorrhagic events.

Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis / Schepis, Filippo; Turco, Laura; Bianchini, Marcello; Villa, Erica. - In: SEMINARS IN LIVER DISEASE. - ISSN 0272-8087. - 38:3(2018), pp. 215-229. [10.1055/s-0038-1660523]

Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis

Schepis, Filippo;Turco, Laura;Bianchini, Marcello;Villa, Erica
2018

Abstract

Cirrhosis represents the end stage of chronic liver disease and its transition from a compensated to a decompensated status is mainly driven by portal hypertension and systemic inflammation. Although relevant modifications in the evaluation of the coagulative balance in cirrhosis across its natural history have occurred and alterations in routine indices of hemostasis have lost their role as indicators of the hemorrhagic risk of patients with liver cirrhosis, these are still perceived as prone to bleed when admitted to invasive procedures. This view, which is still present in guidelines addressing the management of bleeding risk, makes preprocedural transfusion of plasma and platelets still an ongoing clinical practice. In this review, we describe the limitations of both bleeding risk assessment in cirrhotic patients admitted to radiologic and endoscopic invasive procedures and evaluate whether preventive strategies indicated by current guidelines can affect the procedure-related hemorrhagic events.
24-lug-2018
38
3
215
229
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis / Schepis, Filippo; Turco, Laura; Bianchini, Marcello; Villa, Erica. - In: SEMINARS IN LIVER DISEASE. - ISSN 0272-8087. - 38:3(2018), pp. 215-229. [10.1055/s-0038-1660523]
Schepis, Filippo; Turco, Laura; Bianchini, Marcello; Villa, Erica
File in questo prodotto:
File Dimensione Formato  
s-0038-1660523.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 286.17 kB
Formato Adobe PDF
286.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1167684
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 32
social impact